Balaji Telefilms Q1 net profit at Rs 49.39 million

Balaji Telefilms Ltd has posted a net profit of Rs 49.39 million for the quarter ended June 30, 2001 on a total income of Rs 236.86 million for the quarter ended June 30, 2001. The figures of corresponding quarter of previous year have not been drawn since the listing requirements were not applicable.

Mindteck appoints Sumit Ganguli as Group CEO

Mindteck, a global software services company specialized in business applications and embedded technologies today (August 1, 2001) announced the appointment of Sumit Ganguli as its Group Chief Executive Officer. The appointment is especially significant as it comes at a time when the company is consolidating its international operations through the acquisition of US-based software services company Infotech Holdings Inc, making it over four times its present size by revenue.

Cadila Healthcare acquires 39,279 equity shares of German Remedies through open market

Cadila Healthcare Ltd has informed BSE that today pursuant to the open offer made by Recon to the shareholders of GRL, Cadila has today (August 1, 2001) acquired 39,279 equity shares of German Remedies Ltd representing 0.4763% of the paid up capital through open market purchases as permitted under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulation 1997. The maximum price paid for shares acquired through open market purchases was Rs 468.63 per share.

Hindalco Q1 net down by 8.36%

Hindalco Industries Ltd has posted a net profit of Rs 1611 million for the quarter ended June 30, 2001 as compared to Rs 1758 million in the corresponding period last fiscal. Net Sales for the quarter ended June 30, 2001 are at Rs 5490 million as compared to Rs 5652 million in JQ 2000. Other income has increased from Rs 307 million in the quarter ended June 30, 2000 to Rs 326 million in the quarter ended June 30, 2001. The company has provided Rs 111 million towards provision for deferred tax during the quarter ended June 30, 2001.

Aurobindo Pharma Q1 net down by 47.08%

Aurobindo Pharma Ltd has posted a net profit of Rs 112.70 million for the quarter ended June 30, 2001 as compared to Rs 213 million in the corresponding period last fiscal. Total Income for the quarter ended June 30, 2001 is at Rs 1899.60 million as compared to Rs 2161 million in the corresponding period last fiscal. Chennai Port strike and also upgradation process at some of the plants to comply with US FDA and European Regulations have resulted in reduced production and sales in Q1 of current quarter.

Hotel Leela Venture allots Cumulative Redeemable Pref shares on private placement basis

Hotel Leela Venture Ltd has informed BSE that the Committee of Directors for issue of shares have allotted Cumulative Redeemable Preference Shares of Rs.100 each for an aggregate amount of Rs.120 million on private placement basis.

Mphasis & Epicentric partner to provide customers with fully integrated & customized e-business networks

Mphasis, a leading provider of system integration services for customer-focussed corporations, and Epicentric, Inc.,a leader in developing e-Business Network solutions and next generation portal solutions, today (August 1, 2001) announced that they have partnered to provide seamless integration and professional services that help customers launch personalized, customizable, and scaleable e-business centers and networks. Mphasis and Epicentric have also announced that Shinsei Bank of Japan will be first customer to benefit from this partnership. The companies are currently collaborating to support the implementation of Shinsei's revolutionary new retail banking distribution system. MphasiS is using Epicentric's portal technology to integrate Shinsei's portal technology to integrate Shinsei's Internet banking with the bank's back-end systems and Client Relationship Management systems. "With MphasiS' strong expertise in banking processes and their strong enterprise integration skills, we are leveraging Epicentric's platform to deliver the next generation portal to the Japanese financial world. Epicentric provides Shinsei Bank with state-of-the-art capability ad scalability to deliver a well integrated range of services and world-class experience to our customers", according to Pieter Franken, General Manager of Shinsei's Information Technology Division.

Gujarat Petrosynthese Board approves merger of Karnataka Petrosyntheses

Gujarat Petrosynthese Ltd has informed BSE that the Board of Directors of the company has accorded in principle approval for merger/amalgamation of the Karnataka Petrosyntheses Ltd. with the company, subject to necessary approvals.

N Wadia appointed as Deputy MD of Bombay Dyeing

Bombay Dyeing & Manufacturing Co Ltd has informed BSE that 1. Mr S S Kelkar has retired as Executive Director of the company with effect from the close of business on July 31, 2001. He will however continue as an ordinary Director from August 1, 2001. 2. Mr Ness N Wadia with effect from August 1, 2001 has been appointed as Deputy Managing Director.

Bharat Electronics Q1 net up by 39.89%

Bharat Electronics Ltd has posted a net profit of Rs 135 million for the quarter ended June 30, 2001 as compared to Rs 96.50 million for the quarter ended June 30, 2000. Total Income for the quarter ended June 30, 2001 is at Rs 1741.10 million as against Rs 1400.60 million in the corresponding period last fiscal. With good order book position, sales and production are expected to pick up in subsequent quarters.

Chambal Fertilisers approves investment in US Software Co

Chambal Fertilisers & Chemicals Ltd has informed BSE that the Board of Directors of the company has approved the investment upto US$ 12 million in a US based software company in phased manner. Negotiations are under way.

Swaraj Engines Q1 net up by 7.84%

Swaraj Engines Ltd has posted a net profit of Rs 27.50 million for the quarter ended June 30, 2001 as compared to Rs 25.50 million in the corresponding period last fiscal. Total Income has increased from Rs 242.50 million in JQ 2000 to Rs 245 million in the quarter ended June 30, 2001.

Godrej Foods to demerge its manufacturing division

Godrej Foods Ltd has informed BSE that the Board of Directors of the company have taken an in principle decision to restructure Godrej Foods Ltd., (GFL) by demerging its manufacturing division into Godrej Industries Ltd.,(GIL) subject to necessary approvals. The exchange ratio as per the scheme of arrangement is 1 share of GIL (face value Rs.6) for 15 shares of GFL (face value Rs.10)

Dr Reddy's anticipates to launch Fluoxetine 40mg capsules on August 03, 2001

Dr. Reddy's Laboratories Ltd has announced today (July 31, 2001) that the District Court for the Southern District of Indiana has in a final Judgement on July 27, 2001, invalidated a December 2003 patent protecting Eli Lilly & Co.'s Prozac anti-depressant. This final court order should clear the way for Dr. Reddy's Launch of fluoxetine 40 mg capsules no later than the other generic drug manufacturers with marketing exclusivity. The ruling by the Indiana Court permits Dr. Reddy's to launch its product without having to wait for a Supreme Court decision on Lilly's petition. This ruling follows the decision of the U.S. Courts of Appeals, Federal Circuit in Washington, D.C. earlier this month ruling in favour of Barr Laboratories, Inc. not to rehear the patent-infringement case. In a separate court proceeding on July 18, 2001, Dr. Reddy's was successful in having the final outcome of its case tied to the final outcome of the Barr litigation. This ensures that Dr. Reddy's has the ability to launch the product at the same Barr. Dr. Reddy's expects to launch the products on the expiration of Lilly's pediatric exclusivity for Prozac on August 2, 2001. Dr. Reddy's currently has a tentative approval from the USFDA and experts to get the final approval very soon. On the successful launch of the product, Dr. Reddy's will become the first Indian company to get 180-day marketing exclusively in the highly competitive US generic market. Fluoxetine 40 mg capsules is one of the 14 generic pharmaceutical products covered in the exclusive co-marketing and development agreement with its US alliance partners.

DCM Shriram Cons Board approves hiving off of its Polymer Processing business

DCM Shriram Consolidated Ltd has informed BSE that the Board of Directors of the Company at its meeting held meeting today (July 31, 2001) has approved the following: 1. Hiving off of its Polymer Processing Business on a going concern basis to its 91% subsidiary DCM Shriram Exports Ltd, through a Scheme of Arrangement effective from July 1, 2001 at a total consideration of Rs. 435 million, and 2. Setting up of a Wholly Owned Subsidiary (WOS) outside India with capital of upto US $ 3.5 milliion.

Cyanamid Agro fixes record date for the purpose of Scheme of Amalgamation

Cyanamid Agro Ltd has fixed August 31, 2001 as the Record Date for the purpose of the Scheme of Amalgamation of Cyanamid Agro Ltd., with BASF India Ltd., two equity shares of Rs10 each of BASF India Ltd., will be allotted for every five existing equity shares of Rs 10 each of Cyanamid Agro Ltd. held. There will be no dealings in the above mentioned scrip from August 13, 2001.

American Remedies fixes record date for the purpose of Scheme of Amalgamation

American Remedies Ltd has fixed August 28, 2001 as the record date for the purpose of the Scheme of Amalgamation of American Remedies Ltd., with Dr.Reddy's Laboratories Ltd., one equity share of Rs.10 each of Dr.Reddy's Laboratories Ltd., will be allotted for every twelve existing equity shares of Rs.10 each of American Remedies Ltd. held. There will be no dealings in the above mentioned scrip from August 13, 2001.

Blue Dart Express fixes Record Date for Bonus issue

Blue Dart Express Ltd has fixed August 28, 2001 as the Record Date for the purpose of issuing one bonus share of every one existing equity share held. Transaction in the equity shares of the aforesaid Company will be on cum-entitlement basis upto August 10, 2001 and on ex-entitlement basis from August 13, 2001.

Monsanto India fixes record date for Bonus issue

Monsanto India Ltd has fixed August 31, 2001 as the Record Date for the purpose of the issue of one bonus share for every one existing equity share held. Transaction in the equity shares of the aforesaid Company will be on cum-entitlement basis upto August 10, 2001 and on ex-entitlement basis from August 13, 2001.

Trigyn Tech Q1 net loss at Rs 22.48 million

Trigyn Technologies Ltd has posted a net loss of Rs 22.48 million for the quarter ended June 30, 2001 as against a net profit of Rs 35.16 million in the corresponding period last fiscal. Total Income has decreased from Rs 205.72 million in the quarter ended June 30, 2000 to Rs 144.04 million in the quarter ended June 30, 2001.

BSE advises members not to deal in securities of DSQ Software

BSE has informed the Members of the Exchange that the ad-interim injunction dated 26 July 2001 granted by City Civil Court, Chennai against suspension of trading in DSQ Software Ltd. has been vacated on 31 July 2001 by the said Hon'ble Court. Members have been further advised not to deal in the securities of the DSQ Software Ltd w.e.f. August 02, 2001 There will be no BLESS facility available w.e.f. Wednesday, August 1, 2001.

BSE imposes Special Margin of 25% on 2 scrips

BSE has informed the members of the exchange that Special Margin of 25% in the under mentioned scrips has been imposed with effect from August 1, 2001. Code Name Group 32209 JAMMU & KASHMIR BANK LTD B1 506690 UNICHEM LABORATORIES LTD B1

Flex Engineering Board approves issue of equity shares on preferential basis

Flex Engineering Ltd has informed BSE that the Board of Directors of the company has approved issue of upto a maximum of 5 million equity shares of Rs.10 each on preferential basis to such persons and at such price as may be determined by the Board which shall however be not less than the price calculated in accordance with SEBI Guidelines. This is subject to necessary approvals.

Money

Rapid Information on Stocks & Corporates

Tell us what you think of this report